Fast-fashion giant Shein is facing significant hurdles in its pursuit of a Hong Kong stock exchange listing, with profitability concerns casting a long shadow over its ambitions. The company, which built its
Justice Clarence Thomas has opened up about his early relationship with fellow Supreme Court Justice Samuel Alito in a rare and candid interview setting. Thomas sat down with Senator Ted Cruz on
More
Rolls-Royce has been one of the FTSE 100’s most remarkable turnaround stories since CEO Tufan Erginbilgiç took the helm at the engineering giant. The company’s shares returned an extraordinary 221.6% in 2023,
More
The US stock market saw broad gains on August 28, 2026, as investors assessed the latest economic indicators and positioned ahead of key Federal Reserve commentary. Equities across major indices moved higher,
More
The U.S. Court of Appeals for the Fifth Circuit has rejected a major pharmaceutical industry lawsuit challenging Medicare drug price negotiations under the Inflation Reduction Act. The appeals court affirmed a lower
More
Without binding federal legislation covering all 50 states, noncompete agreements remain firmly governed by individual state laws across the country. This legal fragmentation means employers operating in multiple states face a complex
More
The battle over mail-in ballot rules has returned to its starting point, with a federal judge once again freezing the contested Postal Service regulation. The Supreme Court had lifted an earlier injunction
More
Central banks around the world have continued adding gold to their reserves, a trend that has captured the attention of retail investors seeking exposure to the precious metal. The sustained institutional demand
More
James Cleverly has resigned from Kemi Badenoch’s shadow cabinet to formally launch his bid to become mayor of London. Cleverly, who served as shadow housing and local government secretary, confirmed he would
More
The D.C. Circuit has delivered a significant ruling on how pharmaceutical companies can lose their 180-day market exclusivity periods for generic drugs, raising the bar for what counts as a valid excuse.
More
In-house legal teams are quietly becoming the most consequential battleground in the race to integrate artificial intelligence into the practice of law. While much attention has focused on law firms redesigning themselves
More